UW Carbone Cancer Center Joins Elite National Group
Madison, Wisconsin - The University of Wisconsin Carbone Cancer Center has joined the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 27 of the nation’s leading cancer centers.
NCCN, which is devoted to improving cancer care so that patients can live better lives, voted to expand to include UW Carbone in a vote during a board meeting at its annual conference this past week.
UW Carbone is the only National Cancer Institute (NCI)-designated comprehensive cancer center in Wisconsin, and provides the best available cancer care to more than 31,000 patients each year and participates in more than 250 clinical trials annually.
"As one of the original NCI-designated comprehensive cancer centers, we are delighted to have the opportunity to join the esteemed cancer centers of NCCN, which share our devotion to improving the lives of people with cancer through the rapid application of cancer discovery to cancer care and education," said Dr. Howard Bailey, director of the UW Carbone Cancer Center.
The membership gives UW Carbone’s 280 physicians and scientists a voice in setting the clinical standards for cancer care in the United States. Additionally, UW Carbone Cancer Center investigators and patients will have the opportunity to participate in ground-breaking clinical trials offered through the NCCN Oncology Research Program.
“We are pleased to welcome University of Wisconsin Carbone Cancer Center as a NCCN Member Institution,” said Dr. Robert W. Carlson, NCCN chief executive officer. “UW Carbone’s esteemed cancer center indeed brings unique attributes to the alliance, particularly its comprehensive palliative care program which includes an in-patient unit and consultation service, children’s hospital consultative service, and an outpatient onco-palliative care clinic.”
NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbone Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
Date Published: 04/05/2016